Appgate (APGT) 10-K 29 Jun 20 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2020	Jun. 22, 2020	Sep. 30, 2019
Document and Entity Information [Abstract]
Entity Registrant Name	NEWTOWN LANE MARKETING INC
Entity Central Index Key	0001353538
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Document Type	10-K
Document Period End Date	Mar. 31, 2020
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Public Float			$ 552,254
Entity Common Stock, Shares Outstanding		13,757,550
Entity File Number	000-52776
Entity Interactive Data Current	Yes
Entity Incorporation State Country Code	DE

Balance Sheets

Balance Sheets - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Current Assets
Cash and cash equivalents	$ 13,831	$ 10,778
TOTAL CURRENT ASSETS	13,831	10,778
CURRENT LIABILITIES
Accounts payable and accrued expenses	79,486	59,022
Convertible notes payable - Related Party	347,000	307,000
TOTAL CURRENT LIABILITIES	426,486	366,022
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Preferred stock, $0.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized, 13,757,550 shares issued and outstanding, respectively	13,758	13,758
Additional paid-in capital	2,070,756	2,065,756
Accumulated deficit	(2,497,169)	(2,434,758)
TOTAL STOCKHOLDERS' DEFICIT	(412,655)	(355,244)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 13,831	$ 10,778

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Mar. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized	100,000,000	100,000,000
Common stock, issued	13,757,550	13,757,550
Common stock, outstanding	13,757,550	13,757,550

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Expenses
Selling, general and administrative	$ 46,340	$ 37,058
Interest expense, net	16,071	14,264
Total expense	62,411	51,322
Net loss	$ (62,411)	$ (51,322)
Net loss per share - basic and diluted	$ (0.01)	$ (0.01)
Weighted average shares outstanding - basic and diluted	13,757,550	13,757,550

Statement of Changes in Stockho

Statement of Changes in Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Mar. 31, 2018	$ 0	$ 13,758	$ 2,060,756	$ (2,383,436)	$ (308,922)
Balance, shares at Mar. 31, 2018	0	13,757,550
Contributed services	$ 0	$ 0	5,000	0	5,000
Net loss	0	0	0	(51,322)	(51,322)
Balance at Mar. 31, 2019	$ 0	$ 13,758	2,065,756	(2,434,758)	(355,244)
Balance, shares at Mar. 31, 2019	0	13,757,550
Contributed services	$ 0	$ 0	5,000	0	5,000
Net loss	0	0	0	(62,411)	(62,411)
Balance at Mar. 31, 2020	$ 0	$ 13,758	$ 2,070,756	$ (2,497,169)	$ (412,655)
Balance, shares at Mar. 31, 2020	0	13,757,550

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (62,411)	$ (51,322)
Contributed services	5,000	5,000
Changes in operating assets and liabilities:
Increase in accounts payable and accruals	20,464	13,843
NET CASH USED IN OPERATING ACTIVITIES	(36,947)	(32,479)
NET CASH PROVIDED BY FINANCING ACTIVITIES
Issuance of convertible notes payable - Related Party	40,000	40,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	40,000	40,000
NET CHANGE IN CASH AND CASH EQUIVALENTS	3,053	7,521
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	10,778	3,527
CASH AND CASH EQUIVALENTS AT END OF YEAR	$ 13,831	$ 10,778

Description of Company

Description of Company	12 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF COMPANY	NOTE 1 – DESCRIPTION OF COMPANY Newtown Lane Marketing, Incorporated ("we", "our", "us" or "Newtown") was incorporated in Delaware on September 26, 2005. We previously held the exclusive license to exploit the Dreesen's Donut Brand in the United States with the exception of the states of Florida and Pennsylvania, and in Suffolk County, New York, which Dreesen retained for itself. In August 2007 there was a change in control, as detailed below, and we discontinued our efforts to promote the Dreesen's Donut Brand at that time. The license from Dreesen expired on December 31, 2007. EQUITY TRANSACTIONS On August 8, 2007 (the "Effective Date"), we entered into a Stock Purchase Agreement (the "Purchase Agreement") with Moyo Partners, LLC, a New York limited liability company ("Moyo") and R&R Biotech Partners, LLC, a Delaware limited liability company ("R&R" collectively with Moyo, the "Purchasers"), pursuant to which we sold to them, in the aggregate, approximately, four million four hundred seventy nine thousand two hundred fifty (4,479,250) shares of our common stock, par value $.001 per share ("Common Stock") and ) On the Effective Date: (i) the Purchasers acquired control of Newtown, with (a) R&R acquiring nine million five hundred nine thousand four hundred forty (9,509,440) shares of Common Stock (assuming the conversion by R&R of the four hundred (400) shares of Series A Preferred Stock it acquired pursuant to the Purchase Agreement into five million nine hundred twenty eight thousand (5,928,000) shares of Common Stock) constituting 72% of the then issued and outstanding shares of Common Stock, and (b) Moyo acquiring two million three hundred seventy seven thousand three hundred sixty (2,377,360) shares of Common Stock (assuming the conversion by Moyo of its one hundred (100) shares of Series A Preferred Stock it acquired pursuant to the Purchase Agreement into one million four hundred eighty one thousand five hundred ten (1,481,510) shares of Common Stock) constituting 18% of the then issued and outstanding shares of Common Stock; and (ii) in full satisfaction of our obligations under outstanding convertible promissory notes in the principal amount of $960,000 (the "December Notes"), the Note holders of the December Notes converted an aggregate of $479,811 of principal and accrued interest into 274,200 shares of Common Stock and accepted a cash payment from us in the aggregate amount of $625,030 for the remaining principal balance. On the Effective Date: (i) Arnold P. Kling was appointed to our Board of Directors ("Board") and served together with Vincent J. McGill, a then current director who continued to serve until August 20, 2007, the effective date of his resignation from our Board; (ii) all of our then officers and directors, with the exception of Mr. McGill, resigned from their respective positions with us; (iii) our Board appointed Mr. Kling as president and Kirk M. Warshaw as chief financial officer and secretary; and (iv) we relocated our headquarters to Chatham, New Jersey. Following Mr. McGill's resignation from our Board on August 20, 2007, Mr. Kling became our sole director and president. On October 19, 2007, we effected an amendment to our Certificate of Incorporation to increase to 100,000,000 the number of authorized shares of Common Stock available for issuance (the "Charter Amendment"). As a result of the Charter Amendment, as of October 19, 2007, we had adequate shares of Common Stock available for issuance upon the conversion of all the issued and outstanding shares of Series A Preferred Stock. On December 19, 2007, the holders of all the issued and outstanding shares of Series A Preferred Stock elected to convert all of their shares into shares of Common Stock. As a result, the 500 shares of Series A Preferred Stock outstanding were exchanged for 7,407,540 shares of Common Stock, and all 500 shares of the Series A Preferred Stock were returned to the status of authorized and unissued shares of undesignated preferred stock, par value $.001 per shares. None of the Series A Preferred Stock were outstanding as of the Series A Preferred Elimination Date. In December 2008, we sold 550,000 shares of restricted Common Stock to our Chief Financial Officer, for $2,000. The issuance of these shares was exempt from registration pursuant to Sections 4(2) and 4(6) or the Securities Act of 1933, as amended (the "Act"). The stock certificate representing these shares was imprinted with a legend restricting transfer unless pursuant to an effective registration statement or an exemption from registration under the Act. On May 6, 2013, Ironbound Partners Fund, LLC ("Ironbound") acquired 9,509,440 shares of our outstanding Common Stock (the "Acquired Shares") for an aggregate purchase price of $15,000, or $0.00157737 per share, from the Chapter 7 Trustee of the Estates of Rodman & Renshaw, LLC ("Rodman"), Direct Markets, Inc., and Direct Markets Holdings, Corp. in Chapter 7 bankruptcy proceedings pending in the United States Bankruptcy Court for the Southern District of New York (Cases No. 13-10087, 13-10088 and 13-10089). The Acquired Shares constituted all the shares of Common Stock previously owned by R&R, an affiliate of Rodman, and represented 69.1% of our total issued and outstanding shares of Common Stock as of May 6, 2013. On May 14, 2013, Ironbound loaned $100,000 to us and we issued a convertible promissory note in the principal amount of $100,000 to Ironbound (the "May 2013 Note"). The May 2013 Note was initially issued with a two-year term and bore interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the May 2013 Note was convertible into shares of Common Stock upon the consummation of a "Fundamental Transaction" (as defined in the May 2013 Note) at the "Conversion Price" (as defined in the May 2013 Note). The May 2013 Note was amended in July 2014 in accordance with the Amended and Restated Note, as described below. On July 25, 2014, we raised gross proceeds of $72,000 in a debt financing transaction with Ironbound and, in connection therewith, issued to Ironbound a convertible promissory note (the "2014 Note") in the principal amount of $72,000. The 2014 Note has a maturity date of August 31, 2015 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the 2014 Note is convertible, at the election of Ironbound, into shares of our Common Stock following the consummation of a "Qualified Financing" (as defined in the 2014 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the 2014 Note) at the "Conversion Price" (as defined in the 2014 Note). Further, on July 25, 2014, we issued an amended and restated convertible promissory note (the "Amended and Restated Note" and together with the 2014 Note, the "Prior Notes") to Ironbound in the principal amount of $100,000, in substitution for the May 2013 Note. The Amended and Restated Note extended the maturity of the May 2013 Note to August 31, 2015 and provided for the principal and accrued interest on the May 2013 Note to be convertible, at the election of Ironbound, into shares of our Common Stock following the consummation of a "Qualified Financing" (as defined in the May 2013 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the May 2013 Note) at the "Conversion Price" (as defined in the May 2013 Note). The May 2013 Note otherwise remained unchanged. Effective September 1, 2015, the maturity dates of the Prior Notes was extended from August 31, 2015 to August 31, 2016. On October 30, 2015, Mr. Kling resigned from his position as our sole director and from his position as our President. Also on October 30, 2015, Mr. Warshaw resigned from his positions as our Chief Financial Officer and Secretary. Messrs. Kling's and Warshaw's resignation were not due to any disagreement with the Company or its management on any matter relating to the Company's operations, policies or practices. Prior to Mr. Kling's resignation, our Board of Directors appointed Jonathan J. Ledecky, the managing member of Ironbound, our largest stockholder, to fill the vacancy created by Mr. Kling's resignation and will assume the role of President of the Company. On April 1, 2016, we issued a convertible promissory note (the "2016 Note" and together with the Prior Notes, the "Outstanding Notes") in the principal amount of $10,000 to Ironbound. The 2016 Note has the same terms as the Prior Notes. The proceeds of the 2016 Note was and will be utilized by the Company to fund working capital needs. On July 15, 2016, we issued a convertible promissory note (the "July 2016 Note") in the principal amount of $25,000 to Ironbound Partners Fund, LLC. The July 2016 Note has a maturity date of August 31, 2017 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the July 2016 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the July 2016 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the July 2016 Note) at the "Conversion Price" (as defined in the July 2016 Note). The proceeds of the July 2016 Note will be utilized by the Company to fund working capital needs. Effective September 1, 2016, the maturity dates of the Outstanding Notes was extended from August 31, 2016 to August 31, 2017. On February 14, 2017, we issued a convertible promissory note (the "February 2017 Note") in the principal amount of $50,000 to Ironbound. The February 2017 Note has a maturity date of August 31, 2017 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the February 2017 Note is convertible, at the election of Ironbound, into shares of our common stock following the consummation of a "Qualified Financing" (as defined in the February 2017 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the February 2017 Note) at the "Conversion Price" (as defined in the February 2017 Note). The proceeds of the February 2017 Note will be utilized by the Company to fund working capital needs. Effective September 1, 2017, the maturity dates of the Outstanding Notes was extended from August 1, 2017 to August 31, 2018. In August 2018, the maturity dates of the Outstanding Notes was extended from August 1, 2018 to August 31, 2019. On August 27, 2018, we issued a convertible promissory note (the "August 2018 Note") in the principal amount of $15,000 to Ironbound. The August 2018 Note has a maturity date of August 31, 2019 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the August 2018 Note is convertible, at the election of Ironbound, into shares of our common stock following the consummation of a "Qualified Financing" (as defined in the August 2018 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the August 2018 Note) at the "Conversion Price" (as defined in the August 2018 Note). The proceeds of the August 2018 Note has been and will be utilized by the Company to fund working capital needs. On December 4, 2018, we issued a convertible promissory note (the "December 2018 Note") in the principal amount of $25,000 to Ironbound. The December 2018 Note has a maturity date of August 31, 2019 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the December 2018 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the December 2018 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the December 2018 Note) at the "Conversion Price" (as defined in the December 2018 Note). The proceeds of the December 2018 Note has been and will be utilized by the Company to fund working capital needs. Effective November 12, 2019, the maturity dates of the outstanding promissory notes held by Ironbound was extended from August 31, 2019 to August 31, 2020. On November 27, 2019, we issued a convertible promissory note (the "November 2019 Note") in the principal amount of $40,000 to Ironbound. The November 2019 Note has a maturity date of August 31, 2020 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the November 2019 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the November 2019 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the November 2019 Note) at the "Conversion Price" (as defined in the November 2019 Note). The proceeds of the November 2019 Note have been and will be utilized by the Company to fund working capital needs. THE COMPANY TODAY Since the Effective Date, our main purpose has been to serve as a vehicle to acquire an operating business and we are currently considered a "shell" company in as much as we are not generating revenues, do not own an operating business, and have no specific plan other than to engage in a merger or acquisition transaction with a yet-to-be identified operating company or business. Our principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through a combination with an operating company or business. We will not restrict our potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. The analysis of new business opportunities will be undertaken by or under the supervision of our officers and directors. We have no employees and no material assets.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Newtown's accounting policies are in accordance with accounting principles generally accepted in the United States of America. Outlined below are those policies considered particularly significant. (a) Going Concern: The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates Newtown continuing as a going concern. Our purpose has been to serve as a vehicle to acquire an operating business and we are currently considered a "shell" company inasmuch as we are not generating revenues, we do own an operating business, and have no specific plan other than to engage in a merger or acquisition transaction with a yet-to-be-identified operating company or business. We currently have no definitive agreements or understandings with any prospective business combination candidates and there no assurances that we find a suitable business with which to combine. The implementation of our business objectives is wholly contingent upon a business combination and/or the successful sale of our securities. We intend to utilize the proceeds of any offering, any sales of equity securities or debt securities, bank and other borrowings or a combination of those sources to effect a business combination with a target business which we believe may have significant growth potential. While we may, under certain circumstances, seek to effect business combinations with more than one target business, unless additional financing is obtained, we will not have sufficient proceeds remaining after an initial business combination to undertake additional business combinations. There is no assurance that these plans will be realized in whole or in part. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. Since inception, Newtown has incurred an accumulated deficit of $2,97,169 through March 31, 2020. For the years ended March 31, 2020 and 2019, Newtown had net losses of $62,411 and $51,322, respectively. Newtown has incurred negative cash flow from operating activities since its inception. Newtown has spent, and subject to obtaining additional funding, expects to continue to spend substantial amounts in connection with executing its business strategy. These conditions raise substantial doubt about Newtown's ability to continue as a going concern. (b) Use of Estimates: In preparing financial statements with accounting principles generally accepted in the United States of America, management makes certain estimates and assumptions, where applicable, that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. While actual results could differ from those estimates, management does not expect such variances, if any, to have a material effect on the financial statements. (c) Statement of Cash Flows: For purposes of the statements of cash flows Newtown considers all highly liquid investments purchased with a remaining maturity of three months or less to be cash equivalents. (d) Loss per Common Share: The Financial Accounting Standards Board (FASB) has issued accounting guidance "Earnings Per Share" that provides for the calculation of "Basic" and "Diluted" earnings per share. Basic earnings per share include no dilution and is computed by dividing the loss to common stockholders by the weighted average number of common shares outstanding for the period. All potentially dilutive securities have been excluded from the computations since they would be antidilutive. However, these dilutive securities could potentially dilute earnings per share in the future. As of March 31, 2020 and 2019, we had a total of 886,990 of potentially dilutive securities comprised solely of stock options and shares issuable on the conversion of the convertible note payable for $347,000 and $307,000, respectively. (e) Income Taxes: The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it I more likely than not that such assets will be realized. (f) Financial instruments: The estimated fair values of all reported assets and liabilities which represent financial instruments, none of which are held for trading purposes, approximate their carrying values because of the short term maturity of these instruments or the stated interest rates are indicative of market interest rates. (g) Equity Based Compensation: We adopted the FASB accounting guidance for share based payment transactions. This standard requires us to measure the cost of employee services received in exchange for equity share options granted based on the grant date fair value of the options and applies to all outstanding and vested stock-based awards. In computing the impact, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management's bet estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and we use different assumptions, our stock-based compensation expense could be materially different in the future. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating our forfeiture rate, we analyzed our historical forfeiture rate, the remaining lives of unvested options, and the amount of vested option as a percentage of total options outstanding. If our actual forfeiture rate is materially different from its estimate, or if we reevaluate the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period. The accounting guidance requires the use of a valuation model to calculate the fair value of each stock-based award. We use the Black-Scholes model to estimate the fair value of stock options granted based on the following assumptions: No options were exercised in the year ended March 31, 2020 and 2019. (h) New Accounting Pronouncements: Except as set forth below, management does not believe that any other new accounting pronouncements not yet effective will have a material impact on our financial statements once adopted. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either operating or financing, with such classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, and early adoption is permitted. The adoption of ASU 2016-02 did not have material impact on the Company's financial statements.

Stockholders' Deficit

Stockholders' Deficit	12 Months Ended
	Mar. 31, 2020
Equity [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 3 – STOCKHOLDERS' DEFICIT During the years ended March 31, 2020 and March 31, 2019, the Company recorded a $5,000 contribution to capital for the fair value relating to the use, occupancy and administrative services rendered by the officers. STOCK OPTIONS During the year ended March 31, 2014, we issued 886,990 non-qualified stock options to an officer and consultant. These options have a ten year term with exercise prices ranging from $0.002 to $0.02 per share. Some of these options immediately and other options issued vested 50% upon issuance and the remainder vet on their six month anniversary. A summary of the common stock option activity for officers and consultants as of March 31, 2020 and 2019 and the three years then ended is as follows: Weighted Average Exercise Weighted Average Shares Price Term (Years) Outstanding at March 31, 2018 886,990 $ 0.009 5.2 Granted - 0 0 Exercised - 0 0 Forfeited - 0 0 Expired - 0 0 Outstanding at March 31, 2019 886,990 $ 0.009 4.2 Granted - 0 0 Exercised - 0 0 Forfeited - 0 0 Expired - 0 0 Outstanding at March 31, 2020 886,990 $ 0.009 3.2 Exercisable at March 31, 2020 886,990 $ 0.009 3.2 Based on the last trade or purchase of Newtown's shares at a per share price of $0.15 as of March 31, 2020. The intrinsic value of stock options outstanding was $133,049. The following summarizes certain information regarding stock options at March 31, 2020 Total Weighted Weighted Average Average Exercise Exercise Remaining Price Range Number Price Life $0.00-0.002 520,880 0.002 3.2 $0.01-0.02 366,110 0.020 3.2 886,990

Notes Payable - Related Party

Notes Payable - Related Party	12 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
NOTES PAYABLE - RELATED PARTY	NOTE 4 – NOTES PAYABLE – RELATED PARTY On May 14, 2013, Ironbound Partners Fnd LLC ("Ironbound") loaned $100,000 to us and we issued a convertible promissory note in the principal amount of $100,000 to Ironbound (the May 2013 "Note"). The May 2013 Note was initially issued with a two-year term and bore interest at a rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the May 2013 Note was convertible into shares of Common Stock upon the consummation of a "Fundamental Transaction" (as defined in the May 2013 Note) at the "Conversion Price" (as defined in the May 2013 Note). The May 2013 Note was amended in July 2014 in accordance with the amended and Restated Note, as described below. On July 25, 2014, we raised gross proceeds of $72,000 in a debt financing transaction with Ironbound and, in connection therewith, issued to Ironbound a convertible promissory note (the "2014 Note") in the principal amount of $72,000. The 2014 Note has a maturity date of August 31, 2015 and bears interest at a rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the 2014 Note is convertible, at the election of Ironbound, into shares of our common stock following the consummation of a "Qualified Financing" (as defined in the 2014 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the 2014 Note) at the "Conversion Price" (as defined in the 2014 Note). Further, on July 25, 2014, we issued an amended and restated convertible promissory note (the "Amended and Restated Note" and together with the 2014 Note, the "Prior Notes") to Ironbound in the principal amount of $100,000, in substitution for the May 2013 Note. The Amended and Restated Note extended the maturity of the May 2013 Note to August 31, 2015 and provided for the principal and accrued interest on the May 2013 Note to be convertible, at the election of Ironbound, into shares of our Common Stock following the consummation of a "Qualified Financing" (as defined in the May 2013 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the May 2013 Note) at the "Conversion Price" (as defined in the May 2013 Note). The May 2013 Note otherwise remained unchanged. Effective September 1, 2015, the maturity dates of the Prior Notes was extended from August 31, 2015 to August 31, 2016. On October 30, 2015, Mr. Kling resigned from his position as our sole director and from his position as our President. Also on October 30, 2015, Mr. Warshaw resigned from his positions as our Chief Financial Officer and Secretary. Messrs. Kling's and Warshaw's resignation were not due to any disagreement with the Company or its management on any matter relating to the Company's operations, policies or practices. Prior to Mr. Kling's resignation, our Board of Directors appointed Jonathan J. Ledecky, the managing member of Ironbound, our largest stockholder, to fill the vacancy created by Mr. Kling's resignation and will assume the role of President of the Company. On April 1, 2016, we issued a convertible promissory note (the "2016 Note" and together with the Prior Notes, the "Outstanding Notes") in the principal amount of $10,000 to Ironbound. The 2016 Note has the same terms as the Prior Notes. The proceeds of the 2016 Note was and will be utilized by the Company to fund working capital needs. On July 15, 2016, we issued a convertible promissory note (the "July 2016 Note") in the principal amount of $25,000 to Ironbound. The July 2016 Note has a maturity date of August 31, 2017 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the July 2016 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the July 2016 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the July 2016 Note) at the "Conversion Price" (as defined in the July 2016 Note). The proceeds of the July 2016 Note will be utilized by the Company to fund working capital needs. Effective September 1, 2016, the maturity dates of the Outstanding Notes was extended from August 31, 2016 to August 31, 2017. On February 14, 2017, we issued a convertible promissory note (the "February 2017 Note") in the principal amount of $50,000 to Ironbound. The February 2017 Note has a maturity date of August 31, 2017 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the February 2017 Note is convertible, at the election of Ironbound, into shares of our common stock following the consummation of a "Qualified Financing" (as defined in the February 2017 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the February 2017 Note) at the "Conversion Price" (as defined in the February 2017 Note). The proceeds of the February 2017 Note will be utilized by the Company to fund working capital needs. Effective September 1, 2017, the maturity dates of the Outstanding Notes was extended from August 1, 2017 to August 31, 2018. In August 2018, the maturity dates of the Outstanding Notes was extended from August 1, 2018 to August 31, 2019. On August 27, 2018, we issued a convertible promissory note (the "August 2018 Note") in the principal amount of $15,000 to Ironbound. The August 2018 Note has a maturity date of August 31, 2019 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the August 2018 Note is convertible, at the election of Ironbound, into shares of our common stock following the consummation of a "Qualified Financing" (as defined in the August 2018 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the August 2018 Note) at the "Conversion Price" (as defined in the August 2018 Note). The proceeds of the August 2018 Note has been and will be utilized by the Company to fund working capital needs. On December 4, 2018, we issued a convertible promissory note (the "December 2018 Note") in the principal amount of $25,000 to Ironbound. The December 2018 Note has a maturity date of August 31, 2019 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the December 2018 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the December 2018 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the December 2018 Note) at the "Conversion Price" (as defined in the December 2018 Note). The proceeds of the December 2018 Note has been and will be utilized by the Company to fund working capital needs. Effective November 12, 2019, the maturity dates of the outstanding promissory notes held by Ironbound was extended from August 31, 2019 to August 31, 2020. On November 27, 2019, we issued a convertible promissory note (the "November 2019 Note") in the principal amount of $40,000 to Ironbound. The November 2019 Note has a maturity date of August 31, 2020 and bears interest at the rate of 5.0% per annum, payable at maturity. The principal and accrued interest on the November 2019 Note is convertible, at the election of Ironbound, into shares of the Company's common stock following the consummation of a "Qualified Financing" (as defined in the November 2019 Note), or upon the consummation of a "Fundamental Transaction" (as defined in the November 2019 Note) at the "Conversion Price" (as defined in the November 2019 Note). The proceeds of the November 2019 Note have been and will be utilized by the Company to fund working capital needs.

Income Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 5 – INCOME TAXES Deferred tax assets and liabilities consist of the following: March 31, March 31, 2020 2019 Deferred tax assets: Net operating loss carryforwards & capital loss carry forward 533,640 522,860 Less: valuation allowance (533,640 ) (522,860 ) $ — $ — The provision for income taxes differs from the amount computed by applying the US statutory income tax rate as follows: March 31 2020 2019 Provision for expected federal statutory rate 21 % 21 % Permanent differences – equity based compensation 5 % 5 % Loss for which no benefit is available or a valuation allowance Has been recorded 26 % 26 % At March 31, 2019, Newtown had approximately $2,067,000 of net operating loss carry forwards ("NOL's") available. In addition, there is a $25,000 capital loss carryover, which is fully reserved as well. This capital loss expires in 2026. The utilization of the net operating loss carryforward has been limited as to its use pursuant to the Internal Revenue Code Section 382 due to the recent and past changes in ownership of Newtown. The benefits of these NOL's may be reduced in the future if Newtown is successful in establishing a new business. Newtown's federal and state income tax returns for the years 2015 through 2020 remain open for audit by applicable regulatory authority.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 – COMMITMENTS AND CONTINGENCIES During the years ended March 31, 2020 and March 31, 2019, the Company recorded a $5,000 contribution to capital for the fair value relating to the use, occupancy and administrative services rendered by our officers.

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 7 – SUBSEQUENT EVENTS We have evaluated all subsequent events and determined that there were no subsequent events to recognize or disclose in these financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Going Concern	(a) Going Concern: The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates Newtown continuing as a going concern. Our purpose has been to serve as a vehicle to acquire an operating business and we are currently considered a "shell" company inasmuch as we are not generating revenues, we do own an operating business, and have no specific plan other than to engage in a merger or acquisition transaction with a yet-to-be-identified operating company or business. We currently have no definitive agreements or understandings with any prospective business combination candidates and there no assurances that we find a suitable business with which to combine. The implementation of our business objectives is wholly contingent upon a business combination and/or the successful sale of our securities. We intend to utilize the proceeds of any offering, any sales of equity securities or debt securities, bank and other borrowings or a combination of those sources to effect a business combination with a target business which we believe may have significant growth potential. While we may, under certain circumstances, seek to effect business combinations with more than one target business, unless additional financing is obtained, we will not have sufficient proceeds remaining after an initial business combination to undertake additional business combinations. There is no assurance that these plans will be realized in whole or in part. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. Since inception, Newtown has incurred an accumulated deficit of $2,97,169 through March 31, 2020. For the years ended March 31, 2020 and 2019, Newtown had net losses of $62,411 and $51,322, respectively. Newtown has incurred negative cash flow from operating activities since its inception. Newtown has spent, and subject to obtaining additional funding, expects to continue to spend substantial amounts in connection with executing its business strategy. These conditions raise substantial doubt about Newtown's ability to continue as a going concern.
Use of Estimates	(b) Use of Estimates: In preparing financial statements with accounting principles generally accepted in the United States of America, management makes certain estimates and assumptions, where applicable, that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. While actual results could differ from those estimates, management does not expect such variances, if any, to have a material effect on the financial statements.
Statement of Cash Flows	(c) Statement of Cash Flows: For purposes of the statements of cash flows Newtown considers all highly liquid investments purchased with a remaining maturity of three months or less to be cash equivalents.
Loss per Common Share	(d) Loss per Common Share: The Financial Accounting Standards Board (FASB) has issued accounting guidance "Earnings Per Share" that provides for the calculation of "Basic" and "Diluted" earnings per share. Basic earnings per share include no dilution and is computed by dividing the loss to common stockholders by the weighted average number of common shares outstanding for the period. All potentially dilutive securities have been excluded from the computations since they would be antidilutive. However, these dilutive securities could potentially dilute earnings per share in the future. As of March 31, 2020 and 2019, we had a total of 886,990 of potentially dilutive securities comprised solely of stock options and shares issuable on the conversion of the convertible note payable for $347,000 and $307,000, respectively.
Income Taxes	(e) Income Taxes: The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carryforwards for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it I more likely than not that such assets will be realized.
Financial instruments	(f) Financial instruments: The estimated fair values of all reported assets and liabilities which represent financial instruments, none of which are held for trading purposes, approximate their carrying values because of the short term maturity of these instruments or the stated interest rates are indicative of market interest rates.
Equity Based Compensation	(g) Equity Based Compensation: We adopted the FASB accounting guidance for share based payment transactions. This standard requires us to measure the cost of employee services received in exchange for equity share options granted based on the grant date fair value of the options and applies to all outstanding and vested stock-based awards. In computing the impact, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management's bet estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and we use different assumptions, our stock-based compensation expense could be materially different in the future. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating our forfeiture rate, we analyzed our historical forfeiture rate, the remaining lives of unvested options, and the amount of vested option as a percentage of total options outstanding. If our actual forfeiture rate is materially different from its estimate, or if we reevaluate the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what we have recorded in the current period. The accounting guidance requires the use of a valuation model to calculate the fair value of each stock-based award. We use the Black-Scholes model to estimate the fair value of stock options granted based on the following assumptions: No options were exercised in the year ended March 31, 2020 and 2019.
New Accounting Pronouncements	(h) New Accounting Pronouncements: Except as set forth below, management does not believe that any other new accounting pronouncements not yet effective will have a material impact on our financial statements once adopted. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either operating or financing, with such classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, and early adoption is permitted. The adoption of ASU 2016-02 did not have material impact on the Company's financial statements.

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	12 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of common stock option activity	Weighted Average Exercise Weighted Average Shares Price Term (Years) Outstanding at March 31, 2018 886,990 $ 0.009 5.2 Granted - 0 0 Exercised - 0 0 Forfeited - 0 0 Expired - 0 0 Outstanding at March 31, 2019 886,990 $ 0.009 4.2 Granted - 0 0 Exercised - 0 0 Forfeited - 0 0 Expired - 0 0 Outstanding at March 31, 2020 886,990 $ 0.009 3.2 Exercisable at March 31, 2020 886,990 $ 0.009 3.2
Schedule of exercise price range of stock options	Total Weighted Weighted Average Average Exercise Exercise Remaining Price Range Number Price Life $0.00-0.002 520,880 0.002 3.2 $0.01-0.02 366,110 0.020 3.2 886,990

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets and liabilities	March 31, March 31, 2020 2019 Deferred tax assets: Net operating loss carryforwards & capital loss carry forward 533,640 522,860 Less: valuation allowance (533,640 ) (522,860 $ — $ —
Schedule of provision for income taxes	March 31 2020 2019 Provision for expected federal statutory rate 21 % 21 % Permanent differences – equity based compensation 5 % 5 % Loss for which no benefit is available or a valuation allowance Has been recorded 26 % 26 %

Description of Company (Details

Description of Company (Details Textual) - USD ($)

Jul. 25, 2014

May 06, 2013

Dec. 19, 2007

Aug. 08, 2007

Dec. 31, 2008

Mar. 31, 2020

Nov. 27, 2019

Mar. 31, 2019

Dec. 04, 2018

Aug. 27, 2018

Feb. 14, 2017

Jul. 15, 2016

Apr. 02, 2016

May 14, 2013

Oct. 19, 2007

Preferred stock, outstanding

Preferred stock, par value (in dollars per share)

$ 0.001

$ 0.001

Restricted Stock [Member]

Stock issued during period restricted stock

550,000

Value of stock issued during period restricted stock

$ 2,000

Stock Purchase Agreement [Member] | August 2018 Note Due on August 31, 2019 [Member]

Number of shares converted

274,200

Principal and accrued interest

$ 479,811

Principal payments made on notes payable

625,030

Stock Purchase Agreement [Member] | Moyo Partners, LLC [Member] | August 2018 Note Due on August 31, 2019 [Member]

Principal amount

$ 960,000

Series A Preferred Stock [Member]

Preferred stock, outstanding

500

Preferred stock, shares subscribed but unissued

500

Preferred stock, par value (in dollars per share)

$ 0.001

Stock conversion of convertible securities

7,407,540

Series A Preferred Stock [Member] | Stock Purchase Agreement [Member]

Number of shares issued

500

Share price

$ 0.001

Series A Preferred Stock [Member] | Stock Purchase Agreement [Member] | R and R Biotech Partners, LLC [Member]

Number of shares issued

400

Series A Preferred Stock [Member] | Stock Purchase Agreement [Member] | Moyo Partners, LLC [Member]

Number of shares issued

100

Common Stock [Member]

Number of authorized shares increased

100,000,000

Common Stock [Member] | Stock Purchase Agreement [Member]

Number of shares issued

4,479,250

Share price

$ 0.001

Number of shares converted

14,820

Aggregate gross proceeds

$ 600,000

Common Stock [Member] | Stock Purchase Agreement [Member] | R and R Biotech Partners, LLC [Member]

Number of shares issued

9,509,440

Number of shares converted

5,928,000

Common stock issued and outstanding, percentage

72.00%

Common Stock [Member] | Stock Purchase Agreement [Member] | Moyo Partners, LLC [Member]

Number of shares issued

2,377,360

Number of shares converted

1,481,510

Common stock issued and outstanding, percentage

18.00%

Ironbound Partners Fund LLC [Member] | August 2018 Note Due on August 31, 2019 [Member]

Principal amount

$ 15,000

Ironbound Partners Fund LLC [Member] | November 2019 Not Due onAugust 31, 2020 [Member]

Principal amount

$ 40,000

$ 25,000

Ironbound Partners Fund LLC [Member] | February 2017 Note Due on August 31, 2017 [Member]

Principal amount

$ 50,000

Ironbound Partners Fund LLC [Member] | July 2016 Note Due on August 31, 2017 [Member]

Principal amount

$ 25,000

Ironbound Partners Fund LLC [Member] | Note 2016 Due on August 31, 2015 [Member]

Principal amount

$ 10,000

Ironbound Partners Fund LLC [Member] | Note 2014 Due on August 31, 2015 [Member]

Aggregate gross proceeds

$ 72,000

Principal amount

72,000

Ironbound Partners Fund LLC [Member] | May 2013 Note [Member]

Ironbound loan

$ 100,000

Principal amount

$ 100,000

Ironbound Partners Fund LLC [Member] | Amended and Restated [Member] | Note 2014 Due on August 31, 2015 [Member]

Principal amount

$ 100,000

Ironbound Partners Fund LLC [Member] | Common Stock [Member]

Share price

$ 0.00157737

$ 0.15

Common stock issued and outstanding, percentage

69.10%

Number of shares acquired, Value

$ 15,000

Number of shares acquired

9,509,440

Description of Company (Detai_2

Description of Company (Details Textual 1) - Ironbound Partners Fund LLC [Member] - USD ($)	Jul. 25, 2014	May 14, 2013	Nov. 27, 2019	Dec. 04, 2018	Aug. 27, 2018	Feb. 14, 2017	Jul. 15, 2016
Note 2014 Due on August 31, 2015 [Member]
Aggregate gross proceeds	$ 72,000
Interest rate	5.00%
May 2013 Note Due on August 31, 2015 [Member]
Aggregate gross proceeds		$ 100,000
Term of debt instrument		2 years
Interest rate		5.00%	5.00%
December 2018 Note Due on August 31, 2019 [Member]
Interest rate				5.00%
August 2018 Note Due on August 31, 2019 [Member]
Interest rate					5.00%
February 2017 Note Due on August 31, 2017 [Member]
Interest rate						5.00%
July 2016 Note Due on August 31, 2017 [Member]
Interest rate							5.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Summary of Significant Accounting Policies (Textual)
Accumulated deficit	$ (2,497,169)	$ (2,434,758)
Net loss	$ (62,411)	$ (51,322)
Potentially dilutive securities	886,990	886,990
Convertible note payable	$ 347,000	$ 307,000
Options

Stockholders' Deficit (Details)

Stockholders' Deficit (Details) - $ / shares	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Equity [Abstract]
Outstanding at beginning, Shares	886,990	886,990
Granted, Shares
Exercised, Shares
Forfeited, Shares
Expired, Shares
Outstanding at ending, Shares	886,990	886,990
Exercisable at ending, Shares	886,990
Outstanding at beginning, Weighted Average Exercise Price	$ 0.009
Granted, Weighted Average Exercise Price	0	$ 0
Exercised, Weighted Average Exercise Price	0	0
Forfeited, Weighted Average Exercise Price	0	0
Expired, Weighted Average Exercise Price	0	0
Outstanding at end, Weighted Average Exercise Price	0.009	$ 0.009
Exercisable at end, Weighted Average Exercise Price	$ 0.009
Outstanding at beginning, Weighted Average Remaining Contractual Term (Years)	4 years 2 months 12 days	5 years 2 months 12 days
Outstanding at end, Weighted Average Remaining Contractual Term (Years)	3 years 2 months 12 days	4 years 2 months 12 days
Exercisable at end, Weighted Average Remaining Contractual Term (Years)	3 years 2 months 12 days

Stockholders' Deficit (Details

Stockholders' Deficit (Details 1)	12 Months Ended
	Mar. 31, 2020$ / sharesshares
Total Number	886,990
Exercise Price $0.00-0.002 [Member]
Total Number	520,880
Total Weighted Average Exercise Price | $ / shares	$ 0.002
Total Weighted Average Remaining Life	3 years 2 months 12 days
Exercise Price $0.01-0.02 [Member]
Total Number	366,110
Total Weighted Average Exercise Price | $ / shares	$ 0.020
Total Weighted Average Remaining Life	3 years 2 months 12 days

Stockholders' Deficit (Detail_2

Stockholders' Deficit (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2020	May 06, 2013	Aug. 08, 2007
Non-Qualified Stock Options [Member]
Stockholders' Deficit (Textual)
Stock optoins, description	We issued 886,990 non-qualified stock options to an officer and consultant. These options have a ten year term with exercise prices ranging from $0.002 to $0.02 per share. Some of these options immediately and other options issued vested 50% upon issuance and the remainder vet on their six month anniversary.
Stock Purchase Agreement [Member] | Series A Preferred Stock [Member]
Stockholders' Deficit (Textual)
Share price (in dollars per share)				$ 0.001
Stock Purchase Agreement [Member] | Common Stock [Member]
Stockholders' Deficit (Textual)
Share price (in dollars per share)				$ 0.001
Ironbound Partners Fund LLC [Member] | Common Stock [Member]
Stockholders' Deficit (Textual)
Share price (in dollars per share)		$ 0.15	$ 0.00157737
Intrinsic value of stock options outstanding		$ 133,049

Notes Payable - Related Party (

Notes Payable - Related Party (Details) - Ironbound Partners Fund, LLC [Member] - USD ($)

Nov. 27, 2019

Nov. 12, 2019

Dec. 04, 2018

Aug. 31, 2018

Aug. 27, 2018

Sep. 01, 2017

Feb. 14, 2017

Sep. 01, 2016

Jul. 15, 2016

Sep. 01, 2015

Jul. 25, 2014

May 14, 2013

Apr. 02, 2016

Amended and Restated Note [Member]

Notes Payable - Related Party (Textual)

Debt Instrument, Maturity Date, Description

The maturity dates of the outstanding promissory notes held by Ironbound was extended from August 31, 2019 to August 31, 2020.

2014 Note [Member]

Notes Payable - Related Party (Textual)

Aggregate gross proceeds

$ 72,000

Interest rate

5.00%

Principal amount of convertible promissory note

$ 72,000

Maturity date

Aug. 31, 2015

2014 Note [Member] | Amended and Restated Note [Member]

Notes Payable - Related Party (Textual)

Principal amount of convertible promissory note

$ 100,000

May 2013 Note [Member]

Notes Payable - Related Party (Textual)

Aggregate gross proceeds

$ 100,000

Term of debt instrument

2 years

Interest rate

5.00%

5.00%

Principal amount of convertible promissory note

$ 100,000

February 2017 Note [Member]

Notes Payable - Related Party (Textual)

Interest rate

5.00%

Principal amount of convertible promissory note

$ 50,000

Maturity date

Aug. 31, 2017

Debt Instrument, Maturity Date, Description

Notes was extended from August 1, 2018 to August 31, 2019.

Notes was extended from August 1, 2017 to August 31, 2018.

July 2016 Note [Member]

Notes Payable - Related Party (Textual)

Interest rate

5.00%

Principal amount of convertible promissory note

$ 25,000

Maturity date

Aug. 31, 2017

Debt Instrument, Maturity Date, Description

Notes was extended from August 31, 2016 to August 31, 2017.

2016 Note [Member]

Notes Payable - Related Party (Textual)

Principal amount of convertible promissory note

$ 10,000

August 2018 Note [Member]

Notes Payable - Related Party (Textual)

Interest rate

5.00%

Principal amount of convertible promissory note

$ 25,000

Maturity date

Aug. 31, 2019

August 2018 Note [Member] | Amended and Restated Note [Member]

Notes Payable - Related Party (Textual)

Principal amount of convertible promissory note

$ 100,000

Debt Instrument, Maturity Date, Description

Notes was extended from August 31, 2015 to August 31, 2016.

Note extended the maturity of the May 2013 Note to August 31, 2015.

August 2018 Note [Member]

Notes Payable - Related Party (Textual)

Interest rate

5.00%

Principal amount of convertible promissory note

$ 15,000

Maturity date

Aug. 31, 2019

August 31, 2020 [Member]

Notes Payable - Related Party (Textual)

Interest rate

5.00%

Principal amount of convertible promissory note

$ 40,000

Maturity date

Aug. 31, 2020

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Deferred tax assets:
Net operating loss carryforwards & capital loss carry forward	$ 533,640	$ 522,860
Less: valuation allowance	(533,640)	(522,860)
Deferred tax assets

Income Taxes (Details 1)

Income Taxes (Details 1)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Provision for expected federal statutory rate	21.00%	21.00%
Permanent differences - equity based compensation	5.00%	5.00%
Loss for which no benefit is available or a valuation allowance Has been recorded	26.00%	26.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual)	12 Months Ended
	Mar. 31, 2020USD ($)
Income Taxes (Textual)
Net operating loss carry forwards	$ 2,067,000
Capital loss carryforwards	$ 25,000
Capital loss carryforwards expiration period, description	This capital loss expires in 2026.

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Commitments and Contingencies (Textual)
Contribution to capital	$ 5,000	$ 5,000